A practical guide to using medicines to manage overweight and obesity
References
NICE guidance on overweight and obesity
Overweight and obesity management (2025) NICE guideline NG246
Tirzepatide for managing overweight and obesity (2024) NICE technology appraisal guidance 1026
Semaglutide for managing overweight and obesity (2023) NICE technology appraisal guidance 875. Last updated 4 September 2023
Digital technologies for delivering multidisciplinary weight-management services: early value assessment (2023) NICE health technology evaluation 14. Last updated 6 March 2024
Liraglutide for managing overweight and obesity (2020) NICE technology appraisal guidance 664
NICE guidance on weight-related comorbidities
Cardiovascular disease: risk assessment and reduction, including lipid modification (2023) NICE guideline NG238
Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s (2021) NICE guideline NG202
Hypertension in adults: diagnosis and management (2019) NICE guideline NG136. Last updated 21 November 2023
Eating disorders: recognition and treatment (2017) NICE guideline NG69. Last updated 16 December 2020
Multimorbidity: clinical assessment and management (2016) NICE guideline NG56
Non-alcoholic fatty liver disease (NAFLD): assessment and management (2016) NICE guideline NG49
Type 2 diabetes in adults: management (2015) NICE guideline NG28. Last updated 29 June 2022
Other related NICE guidance
Behaviour change: individual approaches (2014) NICE guideline PH49
ISBN: 978-1-4731-6884-8
This page was last updated: